BTCY Biotricity Inc.

Biotricity, Inc. engages in the provision of biometric data monitoring solutions. The firm offers the Bioflux, a single-unit mobile cardiac telemetry device. It also develops Biolife, which is intended for chronic disease prevention. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

$1.03  -0.01 (-0.96%)
As of 11/23/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  02/18/2016
Outstanding shares:  50,431,245
Average volume:  205,768
Market cap:   $51,944,182
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy